Stigma of opioid addiction barrier to improving care

INCREASED COMPETITION: Dr. Jason Spangler, foreground, executive director of medical policy and quality strategies for Amgen, speaks during the Oct. 5 PBN Health Care Summit about how Amgen is working to lower prescription drug costs by increasing competition. / PBN PHOTO/RUPERT WHITELEY
INCREASED COMPETITION: Dr. Jason Spangler, foreground, executive director of medical policy and quality strategies for Amgen, speaks during the Oct. 5 PBN Health Care Summit about how Amgen is working to lower prescription drug costs by increasing competition. / PBN PHOTO/RUPERT WHITELEY
The stigma surrounding the opioid addiction is similar to that of the AIDS epidemic in recent decades, says Dr. Martin Serota, chief medical officer for Prospect Charter­Care Health Partners. The AIDS crisis became much more manageable with the cooperation of doctors, researchers and the pharmaceutical industry, he said. “We need to do the same thing…
To read the full story, Subscribe or
Subscribe to PBN
- Advertisement -